GKIM
ZBH icon

GW&K Investment Management’s Zimmer Biomet ZBH Stock Holding History

GW&K Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14K Buy
161
+81
+101% +$7.1K ﹤0.01% 859
2026
Q1 		$7K Sell
80
-1
-1% -$92 ﹤0.01% 917
2025
Q4 		$7K Buy
81
+13
+19% +$1.23K ﹤0.01% 908
2025
Q3 		$7K Sell
68
-28
-29% -$2.77K ﹤0.01% 911
2025
Q2 		$9K Sell
96
-11
-10% -$1.06K ﹤0.01% 869
2025
Q1 		$12K Sell
107
-12
-10% -$1.28K ﹤0.01% 772
2024
Q4 		$13K Buy
119
+3
+3% +$322 ﹤0.01% 724
2024
Q3 		$13K Buy
116
+8
+7% +$873 ﹤0.01% 720
2024
Q2 		$12K Buy
108
+5
+5% +$589 ﹤0.01% 696
2024
Q1 		$14K Buy
103
+22
+27% +$2.75K ﹤0.01% 613
2023
Q4 		$10K Buy
81
+3
+4% +$335 ﹤0.01% 689
2023
Q3 		$9K Buy
78
+8
+11% +$1.02K ﹤0.01% 651
2023
Q2 		$10K Buy
+70
New +$9.51K ﹤0.01% 620
2022
Q3 		– Sell
-21
Closed -$2K – 835
2022
Q2 		$2K Buy
21
+5
+31% +$593 ﹤0.01% 785
2022
Q1 		$2K Buy
+16
New +$1.93K ﹤0.01% 738

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

GW&K Investment Management's ZBH Position: Q2 2026 in Review

GW&K Investment Management increased its Zimmer Biomet (ZBH) stake by 101% in Q2 2026, buying an estimated $7.1K and bringing the position to 161 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #859.

GW&K Investment Management first reported a position in ZBH in Q1 2022 and has held it in 15 quarters since. 911 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • GW&K Investment Management held 161 shares of Zimmer Biomet worth $14K as of Q2 2026.
  • GW&K Investment Management bought 81 Zimmer Biomet shares in Q2 2026, an estimated $7.1K.
  • Zimmer Biomet made up ﹤0.01% of GW&K Investment Management's portfolio in Q2 2026, its #859 holding.
  • GW&K Investment Management first reported a position in Zimmer Biomet in Q1 2022 and has held it in 15 quarters since.
  • 911 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.